NO983592D0 - Blandinger avledet fra korn av Eugénia Jambolana Lamarck, fremstilling og bruk av blandingene og noen av deres bestanddeler - Google Patents

Blandinger avledet fra korn av Eugénia Jambolana Lamarck, fremstilling og bruk av blandingene og noen av deres bestanddeler

Info

Publication number
NO983592D0
NO983592D0 NO983592A NO983592A NO983592D0 NO 983592 D0 NO983592 D0 NO 983592D0 NO 983592 A NO983592 A NO 983592A NO 983592 A NO983592 A NO 983592A NO 983592 D0 NO983592 D0 NO 983592D0
Authority
NO
Norway
Prior art keywords
mixtures
eugénia
cereals
constituents
preparation
Prior art date
Application number
NO983592A
Other languages
English (en)
Other versions
NO318694B1 (no
NO983592L (no
Inventor
Albert Rakoto Ratsimamanga
Suzanne Rakoto Ratsimamanga
Philippe Rasoanaivo
Jean Leboul
Jean Provost
Daniel Reisdorf
Original Assignee
Inst Malgache Rech Appl
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Malgache Rech Appl, Rhone Poulenc Rorer Sa filed Critical Inst Malgache Rech Appl
Publication of NO983592L publication Critical patent/NO983592L/no
Publication of NO983592D0 publication Critical patent/NO983592D0/no
Publication of NO318694B1 publication Critical patent/NO318694B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Tea And Coffee (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Steroid Compounds (AREA)
NO19983592A 1996-02-06 1998-08-05 Blandinger avledet fra korn av Eug±nia Jambolana Lamarck, fremstilling og anvendelse av blandingene og noen av deres bestanddeler som medikamenter. NO318694B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9601389A FR2744365B1 (fr) 1996-02-06 1996-02-06 Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments
PCT/FR1997/000207 WO1997028813A1 (fr) 1996-02-06 1997-02-03 Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Publications (3)

Publication Number Publication Date
NO983592L NO983592L (no) 1998-08-05
NO983592D0 true NO983592D0 (no) 1998-08-05
NO318694B1 NO318694B1 (no) 2005-04-25

Family

ID=9488865

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983592A NO318694B1 (no) 1996-02-06 1998-08-05 Blandinger avledet fra korn av Eug±nia Jambolana Lamarck, fremstilling og anvendelse av blandingene og noen av deres bestanddeler som medikamenter.

Country Status (34)

Country Link
US (4) US5972342A (no)
EP (1) EP0879058B1 (no)
JP (2) JP4570694B2 (no)
KR (1) KR100494625B1 (no)
CN (2) CN1080566C (no)
AR (1) AR005726A1 (no)
AT (1) ATE201826T1 (no)
AU (1) AU726628B2 (no)
BG (1) BG63288B1 (no)
BR (1) BR9707613A (no)
CA (1) CA2245701C (no)
CZ (1) CZ292800B6 (no)
DE (1) DE69705108T2 (no)
DK (1) DK0879058T3 (no)
DZ (1) DZ2174A1 (no)
EA (1) EA001463B1 (no)
ES (1) ES2158496T3 (no)
FR (1) FR2744365B1 (no)
GR (1) GR3036007T3 (no)
HU (1) HU227958B1 (no)
IL (1) IL125598A (no)
MA (1) MA24077A1 (no)
NO (1) NO318694B1 (no)
NZ (1) NZ331241A (no)
PL (1) PL186798B1 (no)
PT (1) PT879058E (no)
RS (1) RS49527B (no)
SK (1) SK282672B6 (no)
TN (1) TNSN97031A1 (no)
TR (1) TR199801490T2 (no)
TW (1) TW528598B (no)
UA (1) UA60299C2 (no)
WO (1) WO1997028813A1 (no)
ZA (1) ZA97910B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766182A1 (fr) * 1997-07-17 1999-01-22 Rhone Poulenc Rorer Sa Medicaments contenant des derives de polyhydroxyalkylpyrazine, les nouveaux derives de polyhydroxyalkylpyrazine et leur preparation
JP4443032B2 (ja) 1997-07-17 2010-03-31 アベンテイス・フアルマ・ソシエテ・アノニム ポリヒドロキシアルキルピラジン誘導体、それらの製造およびそれらを含有する医薬
FR2766183B1 (fr) 1997-07-17 1999-08-27 Rhone Poulenc Rorer Sa Medicaments contenant des polyhydroxybutylpyrazines, les polyhydroxybutylpyrazines nouvelles et leur preparation
FR2766184B1 (fr) * 1997-07-17 2000-11-17 Rhone Poulenc Rorer Sa Medicaments contenant en tant que principe actif au moins un derive de polyhydroxylalkylpyrazine, les nouveaux derives de polyhydroxylalkylpyrazine et leur preparation
FR2766180A1 (fr) * 1997-07-17 1999-01-22 Rhone Poulenc Rorer Sa Medicaments contenant en tant que principe actif un derive de 2-(1,2,3,4-tetrahydroxybutyl)pyrazine,nouveaux derives de 2-(1,2,3,4-tetrahydroxybutyl) pyrazine et leur preparation
FR2766185B1 (fr) 1997-07-18 2001-06-15 Rhone Poulenc Rorer Sa Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation
FR2781155B1 (fr) * 1998-07-16 2001-10-26 Rhone Poulenc Rorer Sa Medicaments contenant des derives de polyhydroxyalkylpyrazine, les nouveaux derives de polyhydroxyalkylpyrazine et leur preparation
FR2788274B1 (fr) * 1999-01-11 2001-02-09 Aventis Pharma Sa Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent
WO2000074698A1 (en) * 1999-06-04 2000-12-14 Indian Council Of Medical Research Eugenia jambolina fruit extracts for treating diabetes
JP2003513888A (ja) * 1999-10-12 2003-04-15 ユルグ ラレイダ 神経疾患治療用医薬品
FR2802814B1 (fr) * 1999-12-23 2002-02-22 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique de la famille des sulfonylurees
FR2803515B1 (fr) * 2000-01-06 2002-08-02 Aventis Pharma Sa Solution aqueuse stable de deoxyfructosazine
AUPQ987400A0 (en) * 2000-09-04 2000-09-28 Food Ingredients Technologies Intangibles (Bermuda) Limited Process for selectively extracting bioactive components
US20050255180A1 (en) * 2004-05-14 2005-11-17 Gaurav Tewari Prevention of diabetes by medicinal plants & fruits
JP4615256B2 (ja) * 2004-06-03 2011-01-19 株式会社エヌ・ティー・エイチ フトモモ科植物の含有成分とその用途
US20060266975A1 (en) * 2005-05-27 2006-11-30 Nappa Mario J Compositions comprising 3,3,4,4,5,5,6,6,6-nonafluoro-1-hexene
WO2008004119A2 (en) * 2006-07-06 2008-01-10 Avestha, Gengraine, Technologies, Pvt., Ltd. Eugenia jambolana plant extracts for treating osteoporosis and the extraction process thereof
CN102552231A (zh) * 2011-12-23 2012-07-11 苏州大学 草氨酸钠在制备fto酶抑制剂和减肥药物中的应用
CN113367166B (zh) * 2021-05-13 2022-07-26 海南大学 一种褐背蒲桃提取物杀菌剂及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6114M (no) * 1967-01-19 1968-06-17
US3660571A (en) * 1968-03-28 1972-05-02 Takeda Chemical Industries Ltd Disease control composition for silkworms
DE2159923C3 (de) * 1971-12-02 1974-05-22 Schwabe, Willmar, Dr., 7500 Karlsruhe-Durlach Verfahren zur Gewinnung eines Stoffes mit insulinähnlicher Wirkung und diese Stoffe enthaltende Arzneipräparate
JPS5390401A (en) * 1977-01-13 1978-08-09 Japan Tobacco & Salt Public Improving of smoking taste of cigarette
FR2465484A1 (fr) * 1979-09-21 1981-03-27 Urwerg Suzanne Extrait vegetal a proprietes antidiabetiques et son procede de preparation

Also Published As

Publication number Publication date
CN1325685A (zh) 2001-12-12
CZ243698A3 (cs) 1998-11-11
AU726628B2 (en) 2000-11-16
CA2245701A1 (fr) 1997-08-14
DZ2174A1 (fr) 2002-12-01
PL328415A1 (en) 1999-01-18
KR19990082343A (ko) 1999-11-25
NO318694B1 (no) 2005-04-25
YU4197A (sh) 1999-07-28
US6194412B1 (en) 2001-02-27
EP0879058B1 (fr) 2001-06-06
NO983592L (no) 1998-08-05
CN1148178C (zh) 2004-05-05
ZA97910B (en) 1997-08-01
BR9707613A (pt) 1999-07-27
FR2744365A1 (fr) 1997-08-08
ES2158496T3 (es) 2001-09-01
US6300375B1 (en) 2001-10-09
HUP9902586A3 (en) 2000-01-28
EP0879058A1 (fr) 1998-11-25
CN1080566C (zh) 2002-03-13
WO1997028813A1 (fr) 1997-08-14
AR005726A1 (es) 1999-07-14
RS49527B (sr) 2006-12-15
HUP9902586A2 (hu) 1999-12-28
PT879058E (pt) 2001-10-31
JP4570694B2 (ja) 2010-10-27
JP2010053133A (ja) 2010-03-11
DE69705108T2 (de) 2001-12-20
TW528598B (en) 2003-04-21
US5972342A (en) 1999-10-26
EA001463B1 (ru) 2001-04-23
KR100494625B1 (ko) 2005-09-30
CA2245701C (fr) 2007-09-25
MA24077A1 (fr) 1997-10-01
IL125598A (en) 2002-04-21
DE69705108D1 (de) 2001-07-12
CN1210469A (zh) 1999-03-10
US20020051828A1 (en) 2002-05-02
DK0879058T3 (da) 2001-09-03
BG102673A (en) 1999-09-30
BG63288B1 (bg) 2001-09-28
IL125598A0 (en) 1999-03-12
NZ331241A (en) 1999-09-29
SK105298A3 (en) 1998-12-02
PL186798B1 (pl) 2004-02-27
JP5033857B2 (ja) 2012-09-26
JP2001500103A (ja) 2001-01-09
UA60299C2 (uk) 2003-10-15
EA199800692A1 (ru) 1999-02-25
FR2744365B1 (fr) 1998-02-27
GR3036007T3 (en) 2001-09-28
HU227958B1 (en) 2012-07-30
TR199801490T2 (xx) 1998-10-21
SK282672B6 (sk) 2002-11-06
CZ292800B6 (cs) 2003-12-17
ATE201826T1 (de) 2001-06-15
TNSN97031A1 (fr) 1999-12-31
AU1727197A (en) 1997-08-28

Similar Documents

Publication Publication Date Title
NO983592D0 (no) Blandinger avledet fra korn av Eugénia Jambolana Lamarck, fremstilling og bruk av blandingene og noen av deres bestanddeler
NO20004540D0 (no) Sammensetninger av peptider, formuleringer og anvendelse derav
NO975773L (no) Fremgangsmåter for stabil innarbeiding av substanser i törre, skummede glass-grunnmasser, og sammensetninger oppnådd derved
DE69730039D1 (de) Herztransplantate
NO2011008I1 (no) Bilastine eller et addisjonssalt derav
NO961160L (no) Cykliske forbindelser, deres fremstilling og anvendelse
BR9710090A (pt) Composições pesticidas
BR9709181B1 (pt) composições pesticidas
DK0911385T3 (da) Stanolholdige sammensætninger
FR2744442B1 (fr) Preparation du 1,1,1,3,3-pentachlorobutane et du 1,1,1,3,3,-pentafluorobutane
ATE245356T1 (de) Pestizidzusammensetzungen
NO952575D0 (no) Flytende vanillinblanding, deres fremstilling og anvendelse
DK1437359T3 (da) Hidtil ukendte 3,6-hemiketaler fra 9a-azalidklassen
PT1187847E (pt) Derivados de estreptograminas sua preparacao e as composicoes que os contem
NO991254L (no) FremgangsmÕter og mellomprodukter for fremstilling av substituerte kromanolderivater
IS4809A (is) Taxóíð, efnasmíði þeirra og lyfjasamsetning sem inniheldur þau
NO992562L (no) Anvendelse av blandinger av aktive bestanddeler, inneholdende phytostenoler og/eller phytostenol-estere og potensieringsmidler, for fremstilling av hypo-kolesterinemiske midler
BR9707657A (pt) Benzotiofenos formulações contendo os mesmos e métodos
NO990498D0 (no) 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon
DE69832902D1 (de) Oromukosal-zytokin-zusammensetzungen und ihre verwendung
NO20031142D0 (no) Ny eddik marinalgepulver eller korn og fremgangsmåte for fremstilling av det samme
ATE249451T1 (de) Benzofuranderivate, ihre herstellung und verwendung
ID17640A (id) Susunan pestisida
DK199989D0 (da) Angucyclinoner fra streptomyceter, deres fremstilling og anvendelse
DE69633529D1 (de) Bestimmung des Justierbits

Legal Events

Date Code Title Description
MK1K Patent expired